Emergent BioSolutions
EBS
#6766
Rank
A$0.95 B
Marketcap
A$17.92
Share price
-1.24%
Change (1 day)
25.96%
Change (1 year)

Emergent BioSolutions (EBS) - Net assets

Net assets on the balance sheet as of September 2025 : A$0.87 Billion

According to Emergent BioSolutions 's latest financial reports the company has A$0.87 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Emergent BioSolutions - Net assets on balance sheet (from 2004 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$A$0.77 B-18.55%
2023-12-31$A$0.95 B-53.27%
2022-12-31$A$2.03 B-8.26%
2021-12-31$A$2.22 B18.12%
2020-12-31$A$1.88 B21.04%
2019-12-31$A$1.55 B8.34%
2018-12-31$A$1.43 B22.8%
2017-12-31$A$1.16 B41.28%
2016-12-31$A$0.82 B-8.71%
2015-12-31$A$0.90 B34.03%
2014-12-31$A$0.67 B23.26%
2013-12-31$A$0.54 B28.9%
2012-12-31$A$0.42 B4.68%
2011-12-31$A$0.40 B10.51%
2010-12-31$A$0.36 B35.5%
2009-12-31$A$0.27 B-3.94%
2008-12-31$A$0.28 B44.33%
2007-12-31$A$0.19 B11.45%
2006-12-31$A$0.17 B115.16%
2005-12-31$A$81.64 M175.3%
2004-12-31$A$29.65 M
2002-12-31$A$7.37 M-111.65%
2001-12-31$-A$63.29 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Merck
MRK
A$78.14 B 8,811.07%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
A$0.30 B-65.07%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
A$31.88 B 3,535.36%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
A$0.90 B 2.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$140.15 B 15,882.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$10.92 B 1,145.32%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Soligenix
SNGX
A$11.43 M-98.70%๐Ÿ‡บ๐Ÿ‡ธ USA